eosine yellowish-(ys) has been researched along with Esophageal Squamous Cell Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Lin, G; Ling, Y; Liu, C; Pan, C; Wang, G; Wei, X; Wen, J; Weng, Z; Xie, X; Yang, H; Zhang, H; Zhong, J | 1 |
| Chen, G; Chen, M; Chen, Y; Fang, W; Kang, Z; Li, J; Li, S; Wang, J; Wu, Z; Yao, Q; Zhang, H; Zhang, X; Zheng, F; Zheng, J | 1 |
2 other study(ies) available for eosine yellowish-(ys) and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.
Topics: Eosine Yellowish-(YS); Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Prognosis; Tertiary Lymphoid Structures | 2022 |
Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
Topics: Biomarkers; Chemoradiotherapy; Eosine Yellowish-(YS); Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Hematoxylin; Humans; Lymphocytes, Tumor-Infiltrating; Prognosis; Retrospective Studies | 2023 |